Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
31 March 2026 at 22:49
Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Eli Lilly’s headquarters in Indianapolis. The company, which is flush with cash from sales of its weight-loss drug, has been on a deal-making spree.

© Scott Olson/Getty Images
